Rhabdomyosarcoma

Rellinger Eric, Cooke-Barber, Dasgupta Roshni

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Rhabdomyosarcoma is the most common malignant soft tissue sarcoma seen in the pediatric population. Large cooperative therapeutic studies have contributed to the advances seen in risk stratification and classification based on cytogenetics have led to improvements in the treatment, morbidity, and survival. Molecular profiling has supplanted the role of histopathologic examination in risk stratification. Current treatment strategies include a multimodal approach with a combination of systemic chemotherapy, radiation therapy, surgical resection of the tumor, and surgical evaluation of regional lymph nodes.

Original languageEnglish
Title of host publicationFundamentals of Pediatric Surgery, Third Edition
Pages1047-1054
Number of pages8
ISBN (Electronic)9783031075247
DOIs
StatePublished - Jan 1 2022

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.

Keywords

  • Neoplasm
  • Rhabdomyosarcoma
  • Soft tissue sarcoma
  • Solid tumor
  • Surgical oncology

ASJC Scopus subject areas

  • General Medicine
  • General Nursing

Fingerprint

Dive into the research topics of 'Rhabdomyosarcoma'. Together they form a unique fingerprint.

Cite this